EDGAR Filing Documents for 0001144204-15-059666

Form 8-K/A - Current report: [Amend]

SEC Accession No. 0001144204-15-059666

Filing Date

2015-10-16

Accepted

2015-10-15 19:00:23

Documents

Period of Report

2015-09-16

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K/A	v422209_8ka.htm	8-K/A	31141
2	EXHIBIT 23.1	v422209_ex23-1.htm	EX-23.1	3591
3	EXHIBIT 99.1	v422209_ex99-1.htm	EX-99.1	182007
4	EXHIBIT 99.2	v422209_ex99-2.htm	EX-99.2	260724
5	EXHIBIT 99.3	v422209_ex99-3.htm	EX-99.3	136528
6	EXHBIT 99.4	v422209_ex99-4.htm	EX-99.4	52500
7	GRAPHIC	bdo-logo.jpg	GRAPHIC	2342
	Complete submission text file	0001144204-15-059666.txt		671141

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 8-K/A | Act: 34 | File No.: 001-36288 | Film No.: 151160903
SIC: 2834 Pharmaceutical Preparations